<DOC>
	<DOCNO>NCT01607112</DOCNO>
	<brief_summary>The purpose study assess immunogenicity safety GSK Biologicals ' trivalent influenza vaccine manufacture 2012/2013 influenza season administer adult ( 18 60 year ) elderly ( 60 year ) .</brief_summary>
	<brief_title>A Study Evaluation Immunogenicity Reactogenicity Fluarix/Influsplit SSW 2012/2013 People Aged 18 Years Above</brief_title>
	<detailed_description />
	<criteria>Subjects investigator believe comply requirement protocol . A male female age 18 year time vaccination . Written inform consent obtain subject . Healthy subject subject wellcontrolled chronic disease establish medical history clinical examination enter study . Female subject nonchildbearing potential may enrol study . Female subject childbearing potential may enrol study , subject : practiced adequate contraception 30 day prior vaccination , negative pregnancy test day vaccination , agree continue adequate contraception entire treatment period 2 month completion vaccination . Use investigational nonregistered product study vaccine within 30 day precede dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug within six month prior vaccination . Inhaled topical steroid allow . Administration immunoglobulins and/or blood product within three month precede administration study vaccine plan administration study period . Administration influenza vaccine within six month precede study vaccination . Planned administration/ administration vaccine study vaccine within 30 day study vaccination entire study period . Clinically virologically confirm influenza infection within six month precede study vaccination . Acute disease and/or fever time enrolment . Acute , clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Chronic underlying disease , stabilize clinically serious . History chronic alcohol consumption and/or drug abuse . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . History GuillainBarr√© syndrome . History allergic disease reaction likely exacerbate component vaccine . Anaphylaxis follow administration vaccine ( ) . Pregnant lactate female . Female plan become pregnant planning discontinue contraceptive precaution . Any condition , opinion investigator , prevents subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Healthy</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Elderly</keyword>
	<keyword>Safety</keyword>
	<keyword>Adults</keyword>
</DOC>